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Inhibition of Th1 Differentiation
by IL-6 Is Mediated by SOCS1
Binding of cytokines to their receptor induces receptor
dimerization and association with specific JAK family
members. Activated JAKs cause tyrosine phosphoryla-
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tion, dimerization, and translocation of STATs to theand Mercedes Rinco´n*§
nucleus. Four mammalian JAKs have been indentified* Immunobiology Program
(Jak1, Jak2, Jak3, and Tyk2), and seven STAT factorsDepartment of Medicine
have been characterized (Stat1, Stat2, Stat3, Stat4,Given Medical Building
Stat5a, Stat5b, and Stat6) (reviewed by Leonard andUniversity of Vermont
O’Shea, 1998). This signaling system is relatively promis-Burlington, Vermont 05405
cuous since multiple cytokine receptors use common†Section of Rheumatology
JAKs to phosphorylate specific STATs and multiple cy-Department of Internal Medicine
tokines can signal via a common STAT. Despite theYale University School of Medicine
degenerative aspect of these signaling pathways, eachNew Haven, Connecticut 06520
cytokine maintains its identity and mediates specific‡Department of Biochemistry
biological processes by mechanisms that remain un-St. Jude Children’s Research Hospital
clear, although the use of genetically modified mice hasHoward Hughes Medical Institute
provided a tremendous contribution to this field.Memphis, Tennessee 38120
An additional factor that provides more complexity
to the cytokine network is the recent identification of
negative regulators of cytokine signaling pathways. AnSummary
SH2-containing protein called suppressor of cytokine
signaling (SOCS)/Jak binding protein (JAB)/Stat inducedInterleukin 6 (IL-6) is a cytokine produced by immune
Stat inhibitor (SSI) has recently been identified (Endo etand nonimmune cells and exhibits functional pleiot-
al., 1997; Naka et al., 1997; Starr et al., 1997). Thereropy and redundancy. IL-6 plays an important role in
are eight members of the SOCS family, SOCS1 throughthe differentiation of several cell types. Here, we de-
SOCS7 and cytokine inducible SH2-containing proteinscribe a novel function of IL-6: the negative regulation
(CIS), which control signaling through cytokine recep-of CD41 Th1 cell differentiation. While IL-6-directed
tors and also through other receptor tyrosine kinasesCD41 Th2 differentiation is mediated by IL-4, inhibition
such as the insulin-like growth factor-1 (IGF-1) pathwayof Th1 differentiation by IL-6 is independent of IL-4.
(reviewed by Alexander et al., 1999b; Naka et al., 1999).
IL-6 upregulates suppressor of cytokine signaling 1
SOCS1 mRNA levels are very low in unstimulated bone
(SOCS1) expression in activated CD41 T cells, thereby marrow and liver cells but are rapidly increased in re-
interfering with signal transducer and activator of tran- sponse to stimulation with various cytokines including
scription 1 (STAT1) phosphorylation induced by inter- IL-6, IFNg, and leukemia inhibitory factor (LIF) (Alexan-
feron g (IFNg). Inhibition of IFNg receptor-mediated der et al., 1999b; Naka et al., 1999). Although constitutive
signals by IL-6 prevents autoregulation of IFNg gene expression of SOCS1 occurs in thymus and spleen (Naka
expression by IFNg during CD41 T cell activation, et al., 1997; Starr et al., 1997), the modulation of SOCS1
thereby preventing Th1 differentiation. Thus, IL-6 pro- expression in T cells is unclear. SOCS proteins inhibit
motes CD41 Th2 differentiation and inhibits Th1 differ- signaling through cytokine receptors by interacting di-
entiation by two independent molecular mechanisms. rectly with JAKs to interfere with their catalytic activity
while CIS inhibits cytokine signaling by docking at the
Introduction receptor to block STAT binding (Endo et al., 1997; Naka
et al., 1997; Alexander et al., 1999a).
Cytokines play a key role in the immune response; they The decision of naive CD41 T cells to become Th1 or
Th2 has important consequences in the success of annot only act as growth factors for T and B cells, but they
immune response and the progression of disease (re-also control the differentiation of naive, effector, and
viewed by Murphy, 1998; Murphy et al., 2000). Th1 cellsmemory cells. Cytokines can be pleiotropic due to the
produce IFNg and TNF-b, which are strong inducers offact that a single cytokine can trigger several intracellu-
cell-mediated immunity. Th2 cells produce cytokines suchlar signaling pathways, and they are redundant due to
as IL-4, IL-5, IL-10, and IL-13, which provide signals forthe cross-talk between pathways induced by different
B cell activation and antibody production. In general,cytokines. The Janus protein tyrosine kinase/signal
efficient clearance of intracellular pathogens is basedtransducer and activator of transcription (JAK/STAT)
on innate cell activation, while antibody responses aresignaling pathway is one of the major mechanisms by
best suited for extracellular infections. Cytokines repre-which cytokine receptors transduce intracellular signals.
sent one of the principal factors that determine the dif-
ferentiation of naive CD41 T cells into effector Th1 and§ To whom correspondence should be addressed (e-mail: mrincon@
Th2 cells (reviewed by Constant and Bottomly, 1997;zoo.uvm.edu).
Murphy, 1998; Murphy et al., 2000; Swain, 1995). Thek These authors contributed equally to this work.
presence of IL-4 causes precursor Th cells to differenti-# Present address: Department of Biology, University of North Caro-
lina at Charlotte, Charlotte, North Carolina 28223. ate into Th2, whereas IL-12, IL-18, and IFNg drive Th1
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Figure 1. IL-6 Inhibits the Differentiation of CD41 T Cells into Th1 Cells
(A) Total CD41 T cells (106 cells/ml) purified from wild-type mice were stimulated with ConA (2.5 mg/ml), syngeneic APCs (5 3 105/ml), and
medium alone (2), IL-12 (3.5 ng/ml), or IL-6 (100 ng/ml) plus IL-12. After 4 days, cells were extensively washed and restimulated (106 cells/
ml) for 24 hr with ConA (2.5 mg/ml) alone in the absence of APCs or exogenous cytokines. Supernatants were then harvested and analyzed
for IFNg by ELISA.
(B) Total CD41 T cells were differentiated with ConA and APCs as in (A), in the presence of neutralizing anti-IL-4 mAb (10 mg/ml). Cells were
restimulated for 24 hr with ConA alone, and IFNg levels were determined by ELISA.
(C) CD41 T cells were differentiated with ConA for 4 days in the presence of medium (2), IL-6, or IL-6 and anti-IL-4 mAb and restimulated for
24 hr with Con A. IL-4 levels were analyzed.
(D) CD41 T cells (106 cells/ml) were isolated from AND transgenic mice and stimulated with a cytochrome c peptide (5 mg/ml), APCs (5 3 105/
ml), medium alone (2), IL-12 or IL-12 plus IL-6. Cells were restimulated for 24 hr with cytochrome c peptide and APCs. IFNg levels in the
supernatants were determined by ELISA.
(E) C3H mice were infected with Borrelia burgdorferi and treated with PBS or IL-6. After infection, total CD41 T cells were isolated and
restimulated with B. burgdorferi extracts and APCs for 3 days. The values represent IFNg levels from a pool of CD41 T cells isolated from
four mice and are representative of three experiments carried out.
differentiation (Murphy, 1998). We have demonstrated We have previously described that IL-6 can direct Th2
that IL-6 derived from APCs is able to polarize naive differentiation by stimulating IL-4 production by naive
CD41 T cells into Th2 cells by inducing the initial produc- CD41 T cells (Rinco´n et al., 1997). To determine whether
tion of IL-4 in CD41 T cells (Rinco´n et al., 1997). In IL-6 could have an effect on Th1 differentiation, CD41
addition to their positive effect on differentiation, some T cells were stimulated with Concavalin A (ConA), synge-
cytokines can also exert negative regulation on the dif- neic antigen-presenting cells (APCs), and IL-12 in the
ferentiation of Th1 and Th2 cells. While the signaling presence or absence of IL-6. After 4 days, the cells were
pathways and transcription factors by which cytokines washed and restimulated with ConA for 24 hr, and the
drive differentiation of naive into effector CD41 T cells supernatants were analyzed by ELISA for IFNg, the hall-
have been partially elucidated (Murphy et al., 2000), little mark Th1 cytokine. IFNg production by Th1 cells differ-
is known about the molecular mechanisms that mediate entiated in the presence of IL-6 was substantially dimin-
the negative regulatory effect of cytokines during Th differ- ished compared with cells that were not treated with IL-6
entiation. In this study, we show that IL-6 inhibits Th1 (Figure 1A). These results indicated that the presence
differentiation through an IL-4 independent mechanism.
of IL-6 during the differentiation of CD41 T cells pre-IL-6 interferes with the IFNg signaling pathway and gene
vented the development of high IFNg-producing effectorexpression during differentiation of naive CD41 T cells.
Th1 cells.The molecular mechanism involves activation of STAT3
It has been shown that IL-4 can inhibit Th1 differentia-in response to IL-6 signaling, which leads to subsequent
tion (Seder et al., 1992). To determine whether the abilitySOCS1 gene expression and inhibition of IFNg signaling.
of IL-6 to inhibit the differentiation of Th1 cells was
mediated by an increase in IL-4, we stimulated CD41 TResults
cells in the presence or absence of IL-6 and a neutraliz-
ing anti-IL-4 mAb and restimulated them with ConAIL-6 Inhibits Th1 Differentiation
alone. Even in the presence of an anti-IL-4 mAb, IL-6in an IL-4-Independent Manner
caused a dramatic reduction of the IFNg levels by ef-The local cytokine environment surrounding initial anti-
gen contact is a critical factor in Th1/Th2 differentiation. fector Th1 cells (Figure 1B). Since we have shown that
Inhibition of Th1 Differentiation by IL-6
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Figure 2. Inhibition of Th1 Differentiation by
IL-6 Is Independent of APCs
(A) Total CD41 T cells (106 cells/ml) from wild-
type mice were stimulated with immobilized
anti-CD3 mAb (5 mg/ml), soluble anti-CD28
mAb (1 mg/ml) and IL-12 (3.5 ng/ml), or IL-12
plus IL-6 (100 ng/ml). After 4 days, cells were
washed and restimulated (106 cells/ml) with
immobilized anti-CD3 mAb (5 mg/ml) alone for
24 hr. IFNg production was determined by
ELISA.
(B) Total CD41 T cells were stimulated with
anti-CD3 and anti-CD28 mAbs in the pres-
ence or absence of IL-6 or anti-IL-4 mAb (10
mg/ml) for 4 days. IFNg production was deter-
mined after restimulation.
(C) Cell sorted naive CD41 T cells (5 3 105
cells/ml) were stimulated for 4 days and were
restimulated (5 3 105 cells/ml) with anti-CD3
mAb for 24 hr. IFNg and IL-4 were determined
by ELISA.
Th2 differentiation by IL-6 is dependent on IL-4 (Rinco´n IL-12 and APC-Independent Inhibition
of Th1 Differentiation by IL-6et al., 1997), we tested the neutralizing activity of the
It was possible that the inhibition of Th1 differentiationanti-IL-4 mAb in IL-6-mediated Th2 differentiation. IL-4
by IL-6 was mediated by an indirect effect of IL-6 onproduction by CD41 T cells differentiated in the pres-
APCs instead of direct action on CD41 T cells. To elimi-ence of IL-6 was completely eliminated when anti-IL-4
nate this possibility, CD41 T cells were stimulated withmAb was present in the medium during differentiation
anti-CD3 and anti-CD28 mAbs to provide TcR stimula-(Figure 1C), demonstrating that this antibody completely
tion and necessary costimulation, respectively, and IL-blocked the IL-4 pathway. Together, these data showed
12 in the presence or absence of IL-6. After 4 days,that IL-6 inhibited Th1 differentiation in an IL-4-indepen-
cells were restimulated with anti-CD3 mAb alone. IFNgdent manner.
production by effector cells differentiated in the pres-We examined the ability of IL-6 to inhibit antigen-
ence of IL-12 was very high, whereas effector CD41specific Th1 differentiation. CD41 T cells were isolated
cells that had been differentiated in the presence of IL-from AND TcR-transgenic mice (Kaye et al., 1989) and
12 and IL-6 produced very low amounts of IFNg (Figurewere stimulated with the specific moth cytochrome c
2A). These data demonstrated that IL-6 was able topeptide, APCs, and IL-12 in the presence or absence
inhibit Th1 differentiation through direct action on CD41of IL-6 for 4 days. The cells were then washed and
T cells.restimulated with cytochrome c peptide and APCs. IFNg
Although activated CD41 T cells produce IFNg, theproduction after restimulation was strongly suppressed
presence of IL-12 during the activation of CD41 T cellsin effector cells differentiated in the presence of IL-6
highly enhances IFNg production and promotes Th1 dif-(Figure 1D).
ferentiation (Hsieh et al., 1993; Seder et al., 1993). ToWe and others have shown that Borrelia burgdorferi
determine whether IL-6 could affect Th1 differentiationinfection induces a Th1 response in C3H/HeN mice, as
independently of IL-12, we stimulated CD41 T cells in
measured by elevated IL-12, IFNg, and B. burgdorferi-
the presence or absence of IL-6 for 4 days and then
specific IgG2a antibodies, resulting in Lyme arthritis restimulated them with anti-CD3 mAb alone. In correla-
(Keane-Myers and Nickell, 1995; Matyniak and Reiner, tion with previous studies (Bradley et al., 1996), effector
1995; Anguita et al., 1996). We have also shown that CD41 T cells differentiated in the absence of IL-12 pro-
there is an increased incidence of Lyme arthritis in IL- duced significant amounts of IFNg (Figure 2B). However,
6-deficient mice (Anguita et al., 1997). To determine IL-6 abolished the production of IFNg by effector CD41
whether IL-6 could inhibit the development of a Th1 T cells (Figure 2B). Although the presence of an anti-
response in vivo, we examined the effect of IL-6 adminis- IL-4 mAb during the differentiation enhanced IFNg pro-
tration during B. burgdorferi infection. Mice were in- duction by effector cells (Figure 2B), it did not prevent
fected with B. burgdorferi and concurrently treated with the inhibitory effect of IL-6 (Figure 2B). Thus, IL-6 was
IL-6 or with PBS. After 2 weeks of infection, purified able to inhibit Th1 differentiation in the absence of exog-
CD41 T cells were stimulated ex vivo with B. burgdorferi enous IL-12.
extracts and APCs. Lower IFNg production was de- To eliminate the possible effects of a few contaminant
tected in CD41 cells isolated from infected mice that APCs in the CD41 T cell preparation, we examined the
were treated with IL-6 (Figure 1E). Thus, IL-6 was able to effect of IL-6 on purified naive CD44low CD41 T cells. No
inhibit the development of Th1 effector antigen-specific APCs were detected in the naive CD41 T cell prepara-
tion. The presence of IL-6 during the differentiation ofCD41 T cells in vivo.
Immunity
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Figure 3. IL-6 Inhibits IFNg Gene Expression and Production during Th1 Differentiation
(A) Total CD41 T cells were stimulated with anti-CD3 and anti-CD28 mAbs in the presence or absence of IL-6. Supernatants were harvested
at different time points during the differentiation, and IFNg production was determined by ELISA.
(B) Total RNA from unstimulated CD41 T cells or from CD41 T cells stimulated as in (A) for 2 days was analyzed by RPA. The expression of
IL-2, IFNg, and the housekeeping gene L32 is shown.
(C) IFNg and IL-2 production was examined in the same cell cultures described in (B).
(D) CD41 T cells were stimulated in the presence or absence of IL-6 and anti-IL-4 mAb for 3 days. Total RNA was isolated and analyzed for
cytokine gene expression by RPA.
purified naive cells completely abrogated their ability to was not caused by an increase in IL-4, CD41 T cells
were stimulated in the presence or absence of IL-6 andproduce IFNg after restimulation, while IL-4 production
was increased (Figure 2C). Thus, IL-6 acts directly on a neutralizing anti-IL-4 mAb. The presence of IL-6 during
differentiation resulted in marginal levels of IFNg mRNA,naive CD41 T cells to inhibit IFNg production.
while IL-4, IL-5, IL-10, and IL-13 levels were substantially
enhanced in correlation with our previous report show-IL-6 Inhibits IFNg Production and Gene Expression
ing that IL-6 can drive Th2 differentiation (Figure 3D).during Th1 Differentiation
Interestingly, although the anti-IL-4 mAb abolished theIn addition to effector Th1 cells, naive CD41 T cells also
induction of Th2 cytokines (IL-4, IL-5, IL-10, and IL-13)produce substantial amounts of IFNg after activation
by IL-6, it did not restore the levels of IFNg mRNA (Figureand during differentiation. We therefore examined the
3D). These results clearly demonstrated that IL-6 couldeffect of IL-6 on IFNg production during the differentia-
direct Th2 differentiation and inhibit Th1 differentiationtion period of CD41 T cells. Cells were stimulated with
by two independent molecular mechanisms.anti-CD3 and anti-CD28 mAbs in the presence or ab-
sence of exogenous IL-6. The production of IFNg by
cells stimulated in the presence of IL-6 was dramatically IL-6 Interferes with IFNg Receptor-Mediated
IFNg Productionreduced during differentiation (Figure 3A).
To determine whether the low levels of IFNg detected Although the role of IFNg in Th1 differentiation is some-
what controversial, several studies have shown the re-during the differentiation of CD41 T cells in the presence
of IL-6 were caused by an inhibition of IFNg gene expres- quirement for IFNg for complete Th1 differentiation
(Bradley et al., 1996; Wenner et al., 1996; Wakil et al.,sion, we examined IFNg mRNA levels by ribonuclease
protection assay (RPA). High levels of IFNg transcripts 1998; Yang et al., 1998). Thus, it was possible that the
low levels of IFNg that were produced during CD41 Twere present in cells activated in the absence of IL-6,
but only low levels of IFNg mRNA were observed in cells cell differentiation in the presence of IL-6 were responsi-
ble for impaired Th1 differentiation. To address this pos-stimulated in the presence of IL-6 (Figure 3B). The slight
reduction in the amount of IL-2 mRNA (Figure 3B) was sibility, CD41 T cells were stimulated in the presence
or absence of IL-6 and exogenous IFNg, washed, andnot reproducible, and IL-2 protein secretion was not
affected by IL-6 (Figure 3C). To show that the inhibition restimulated. Low levels of IFNg were produced by ef-
fector cells differentiated with IL-6, even if exogenousof IFNg gene expression by IL-6 during differentiation
Inhibition of Th1 Differentiation by IL-6
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Figure 4. Regulation of IFNg Expression by
IFNg Receptor-Mediated Signals
(A) CD41 T cells were stimulated for 4 days
with anti-CD3 and anti-CD28 mAbs in the ab-
sence (2) or presence of IL-6 and in the ab-
sence (2) or presence of exogenous IFNg
(200 U/ml). Cells were then washed, restimu-
lated for 24 hr, and supernatants were ana-
lyzed for IFNg production by ELISA.
(B) CD41 T cells from wild-type (WT) or
IFNgR-deficient (IFNgR2/2) mice were puri-
fied and stimulated in the absence or pres-
ence of IL-12 (3.5 ng/ml) for 4 days. IFNg pro-
duction as determined by ELISA is shown.
(C) Wild-type or IFNgR2/2 CD41 T cells were
differentiated as in (B) and restimulated with
anti-CD3 for 24 hr. IFNg production values
are presented. These results are representa-
tive of five independent experiments
(D) CD41 T cells from wild-type mice were
stimulated for 24 hr in the presence of me-
dium (2), IFNg, or IL-6. Total RNA was ana-
lyzed by RPA.
IFNg was present during differentiation (Figure 4A). presence of IL-12 (Figure 5A). In contrast, IL-6 did not
affect the low levels of IFNg produced by IFNgR2/2 CD41Thus, the presence of exogenous IFNg during stimula-
tion could not compensate for the inhibitory effect on T cells (Figure 5A), although IL-6 was able to induce IL-4
production in these cells (Figure 5B). Thus, the lack ofTh1 differentiation exerted by IL-6. However, these re-
sults would be expected if the negative regulatory effect IFNgR did not affect IL-6-mediated signals required for
Th2 differentiation but prevented IL-6 from inhibitingof IL-6 on Th1 differentiation was due to an impairment
of the IFNg receptor (IFNgR)-signaling pathways in- Th1 differentiation. Together, these results showed that
inhibition of IFNg gene expression by IL-6 during differ-volved in the upregulation of IFNg gene expression.
To first address the role of IFNgR-mediated signals entiation was taking place downstream of the IFNgR.
in the production of IFNg during the differentiation of
CD41 T cells, we examined IFNg levels in CD41 T cells IL-6 Inhibits Signaling through the IFNg Receptor
by Upregulating SOCS1isolated from mice deficient for the IFNgRa chain
(IFNgR2/2). These mice develop normally with no differ- To understand the molecular mechanism by which IL-6
could interfere with the IFNgR signaling, we first exam-ences in CD41/CD81 subsets but are insensitive to IFNg
treatment (Huang et al., 1993). Wild-type or IFNgR2/2 ined the effect of IL-6 on IFNgR expression during Th
cell differentiation. During activation, the IFNgRa chainCD41 T cells were differentiated in the presence or ab-
sence of IL-12. Even in the presence of IL-12, very low has been shown to be downregulated through internal-
ization after IFNg binding, but it is subsequently recycledlevels of IFNg were found in IFNgR2/2 CD41 T cultures
after 4 days of differentiation (Figure 4B) and after re- to the surface (Bach et al., 1997). Similar levels of IFNgRa
expression were observed in CD41 T cells activated instimulation (Figure 4C). Thus, signaling through the IFNg
receptor has a major role in the differentiation of CD41 the presence or absence of IL-6 (Figure 6A). We also
examined IFNgRb expression. Its expression was veryT cells into IFNg-producing Th1 effector cells in the
presence or absence of IL-12. low in both unstimulated and stimulated CD41 T cells,
in correlation with a previous study (Bach et al., 1997),To further demonstrate the positive autoregulation of
IFNg production in CD41 T cells, we examined IFNg gene but no difference was observed between cells stimu-
lated in the presence or in the absence of IL-6 (data notexpression in response to exogenous IFNg treatment by
RPA. The levels of IFNg mRNA found in CD41 T cells shown). Thus, treatment with IL-6 had no effect on IFNgR
expression during CD41 T cell activation.activated for only 24 hr with anti-CD3 and anti-CD28 in
the presence of exogenous IFNg were higher than the The suppressor of cytokine signaling (SOCS) proteins
play an important role in the negative regulation of cyto-levels in cells activated in its absence (Figure 4D). In
correlation with the above results, IL-6 decreased IFNg kine signaling (reviewed by Alexander et al., 1999b; Naka
et al., 1999). SOCS1 negatively regulates IFNg signalingmRNA levels. Thus, the intracellular signaling pathways
triggered by IFNg enhanced IFNg gene expression dur- in vivo since SOCS1-deficient mice die at 3 weeks of
age due to IFNg hypersensitivity (Naka et al., 1998; Starring the differentiation of CD41 T cells.
To address whether the inhibition of Th1 differentia- et al., 1998; Alexander et al., 1999a; Marine et al., 1999).
Since it was originally described that IL-6 inducestion by IL-6 was mediated by interference with IFNgR-
mediated signaling, we examined the effect of IL-6 in SOCS1 gene expression (Naka et al., 1997; Starr et al.,
1997), we hypothesized that IL-6 could interfere withCD41 T cells deficient for IFNgR. IL-6 inhibited IFNg
production by wild-type CD41 T cells activated in the IFNg signaling by upregulating SOCS1 expression lev-
Immunity
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Figure 5. IL-6 Does Not Interfere with IFNg
Production in CD41 T Cells Lacking the IFNg
Receptor
(A) CD41 T cells from wild-type (WT) or
IFNgR2/2 mice were stimulated with anti-
CD3, anti-CD28 mAbs and IL-12 in the pres-
ence or absence of IL-6. After 4 days, IFNg
production was determined by ELISA.
(B) Wild-type or IFNgR2/2 CD41 T cells were
stimulated with anti-CD3, anti-CD28 mAbs in
the absence or the presence of IL-6 for 4
days, and restimulated with anti-CD3 mAb for
24 hr. IL-4 production in supernatants was
determined by ELISA.
els. To test this hypothesis, CD41 T cells were activated in the presence of IL-6 (Figure 6F). The levels of STAT1
protein were similar in all the conditions. Thus, the IFNg-in the presence or absence of IL-6. Total RNA was iso-
lated and assayed for SOCS1 expression by Northern signaling pathway is impaired in CD41 T cells differenti-
ated in the presence of IL-6.blotting. Although SOCS1 was expressed in activated
CD41 T cells, the presence of IL-6 caused a substantial To further demonstrate that IL-6 inhibited IFNg pro-
duction by CD41 T cells by enhancing SOCS1 expres-upregulation of SOCS1 mRNA levels (3-fold higher than
the stimulation with anti-CD3 and anti-CD28 alone when sion, we examined whether IL-6 failed to inhibit IFNg
production in SOCS1-deficient Th cells (SOCS12/2) (Ma-normalized to g-actin mRNA levels) (Figure 6B). To fur-
ther address the role of IL-6 in SOCS1 gene expression, rine et al., 1999). CD41 T cells from wild-type or
SOCS12/2 littermates were stimulated in the presencecells were stimulated in the presence or absence of anti-
IL-6 mAb. SOCS1 mRNA levels were decreased when or absence of IL-6. The presence of IL-6 completely
blocked the early production of IFNg by wild-type CD41anti-IL-6 mAb was present during differentiation (Figure
6C). These results support the role of physiological lev- T cells, but IL-6 did not affect IFNg production by CD41
T cells that lack SOCS1 (Figure 7A). Similar results wereels of IL-6 in SOCS1 gene expression in activated CD41
T cells. Thus, increased levels of SOCS1 induced by IL-6 obtained when cells were differentiated in the presence
of IL-12 (Figure 7B). These data demonstrate that IL-6could prevent signaling triggered by endogenous IFNg
binding to its receptor. inhibited IFNg signaling and IFNg gene expression by
upregulating SOCS1 gene expression.IL-6-induced SOCS1 expression has been shown to
be mediated by STAT3 in specific cell lines (Naka et al., To characterize the functional role for SOCS1 in IL-6-
mediated Th1 inhibition, we also analyzed the effect of1997), so we examined the levels of STAT3 in the nuclei
of CD41 T cells activated in the presence or the absence IL-6 on STAT1 activation in SOCS12/2-deficient cells.
Unlike SOCS12/2 mice, SOCS12/2 IFNg2/2 mice live nor-of IL-6 by electrophoretic mobility shift assay (EMSA).
Using an anti-STAT3 mAb, no STAT3 binding was de- mally and have a phenotype similar to wild-type mice
(Marine et al., 1999). We therefore examined the effect oftected in CD41 T cells stimulated in the absence of IL-6.
In contrast, we observed that STAT3 was the principal IL-6 on IFNgR-mediated signaling in SOCS12/2 IFNg2/2
CD41 T cells in response to exogenous IFNg. While thecomponent of the STAT binding complex present in
CD41 T cells stimulated in the presence of IL-6 (Figure presence of IL-6 during differentiation inhibited IFNg-
induced STAT1 phosphorylation in IFNg2/2SOCS11/16D). These results demonstrated that IL-6 activates
STAT3 in CD41 T cells. The selective activation of STAT3 cells, IL-6 failed to inhibit STAT1 activation cells in cells
from IFNg2/2SOCS12/2 mice (Figure 7C). Thus, SOCS1could mediate the induction of SOCS1 gene expression
by IL-6. is required for IL-6-mediated inhibition of IFNg signaling
(Figure 7D).To show that elevated levels of SOCS1 induced by
IL-6 in CD41 T cells could inhibit IFNgR-mediated sig-
nals, we examined Tyr- phosphorylation of STAT1. CD41 Discussion
T cells were stimulated for 24 hr in the presence or
absence of IL-6. No phosphorylated STAT1 was de- Cytokines play a critical role in the control of CD41
Th1 and Th2 effector cell differentiation. However, thetected in unstimulated CD41 T cells, but significant lev-
els were found in activated cells (Figure 6E). This phos- molecular mechanisms by which cytokines induce or
repress gene expression and differentiation remain un-phorylation was primarily induced by endogenous IFNg
since the presence an anti-IFNg mAb blocked STAT1 clear. Here, we show that IL-6 can negatively regulate
the differentiation of resting CD41 T cells into effector Th1phosphorylation (Figure 6E). Cells activated in the pres-
ence of IL-6 also exhibited decreased levels of phospho- cells by interfering with the IFNgR signaling pathway.
Although it has been shown that IL-6 and IL-4 canSTAT1 (Figure 6E). To better examine the inhibition of
IFNg-induced STAT1 phosphorylation by IL-6 activated prevent resting T cell apoptosis (Teague et al., 1997,
2000; Ben-Sasson et al., 2000), we have observed onlyCD41, T cells were rested to decrease phospho-STAT1
background and then treated with IFNg. STAT1 phos- a slight (15%–20%) increase in CD41 cell recovery after
differentiation in the presence of IL-6 (data not shown).phorylation was rapidly induced by IFNg in cells stimu-
lated in the absence of IL-6 while no significant induction Despite its potential effect on T cell survival, we and
others have demonstrated that IL-6 is not only a survivalof STAT1 phosphorylation was induced in cells activated
Inhibition of Th1 Differentiation by IL-6
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Figure 6. IL-6 Upregulates SOCS1 Expression and Inhibits IFNg-Induced STAT1 Phosphorylation
(A) Unstimulated CD41 T cells or cells stimulated with anti-CD3 and anti-CD28 mAbs in the presence (thick line) or absence (thin line) of IL-6
for different periods of time were stained with anti-IFNgRa mAb and analyzed by flow cytometry. Histograms represent the mean fluorescence
intensity of IFNgRa staining. The vertical line indicates isotype control staining.
(B) SOCS1 gene expression in unstimulated CD41 T cells or CD41 T cells stimulated for 2 days as described in (A) was analyzed by Northern
blotting using a SOCS1-specific probe. g-actin expression is shown as a loading control.
(C) Northern blot analysis for SOCS1 of total RNA from CD41 T cells stimulated for 2 days with medium (2) or in the presence of anti-IL-6
mAb (10 mg/ml).
(D) Nuclear extracts from CD41 T cells stimulated for 18 hr in the presence (IL-6) or absence (2) of IL-6 were analyzed by EMSA using a
double stranded STAT binding oligonucleotide. Binding reactions were performed in the presence of a rabbit control (CT) or anti-STAT3
(aSTAT3) antiserum. The STAT complexes (STAT binding) and STAT3 supershift (arrow) are shown.
(E) STAT1 phosporylation was determined by Western blotting of whole extracts from unstimulated CD41 T cells (unstim) or from CD41 T
cells stimulated in the presence of medium alone (2), IL-6, or anti-IFNg mAb for 24 hr. Antisera specific for the Y701-phosphorylated form of
STAT1 (p-STAT1) and for STAT1 protein were used for immunoblotting.
(F) CD41 T cells were stimulated in the absence (medium) or presence of IL-6 for 24 hr, washed, rested at 378C for 2 hr and treated with medium
(2) or IFNg (100 U/ml) for 15 or 30 min. Whole cell lysates were analyzed for phospho-STAT1 (pSTAT1) and STAT1 as described in (E).
factor that enhances a general immune response but during infection with B. burgdorferi prevents the genera-
tion of antigen-specific Th1 effector CD41 T cells (Figurealso influences the type of response that is developed
against specific antigens. Thus, IL-6 produced by APCs 1E). In correlation, both systemic administration of IL-6
(Rodriguez et al., 1994) and transgenic expression ofplays an important role in the initiation of Th2 differentia-
tion in vitro (Rinco´n et al., 1997). In addition to its role IL-6 in the central nervous system (Willenborg et al.,
1995) suppress the development of experimental auto-in promoting Th2 differentiation, we demonstrate here
that IL-6 is also able to inhibit in vitro IFNg production immune encephalomyelitis (EAE) wherein progression
has been associated with Th1 immune responses. Theand differentiation of both total CD41 T cells (z95%
CD44low CD45RBhigh naive phenotype) and naive CD41 T treatment with IL-6 in vivo also decreases plasma levels
of IFNg in mice injected with ConA (Mizuhara et al.,cells (Figures 1D and 2C) into effector cells in response
to polyclonal stimuli as well as to specific antigen stimu- 1996) and production of IFNg by CD81 T cells from mice
immunized with Schistosoma mansoni eggs (La Flammelation. The inhibitory effect of IL-6 does not appear to
be dependent on genetic background because similar et al., 2000). The results from in vivo studies of Th1
immune responses in IL-6-deficient mice are less cleareffects were observed in B10.BR (Figures 1, 2, 3, and
6), C3H (Figure 1E), C57Bl/6 (data not shown), 129/Sv probably due to indirect effects of IL-6 gene disruption
on other nonlymphoid cells. Increased resistance to EAE(Figure 5), and C57Bl/63129.J (Figure 7) mouse strains.
In correlation with our results, Joseph et al. (1998) have (Samoilova et al., 1998), impaired neutrophil function
and Th1 response against Candida albicans (Romani etalso observed that IL-6 decreases the levels of IFNg
produced by naive CD41 T cells from AND TcR trans- al., 1996), and failure to control vaccinia virus and Liste-
ria monocytogenes (Kopf et al., 1994) have been ob-genic mice after 3 days of activation in vitro.
We have also shown that IL-6 is able to inhibit in vivo served in IL-6-deficient mice. However, in correlation
with our study, IL-6-deficient mice also develop in-Th1 differentiation since administration of IL-6 in vivo
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Figure 7. IL-6 Fails to Inhibit IFNg Production in SOCS1-Deficient Mice
(A) Total CD41 T cells were isolated from wild-type (WT) or SOCS1-deficient (SOCS12/2) mice and stimulated with anti-CD3 and anti-CD28
mAbs in the absence (2) or presence of IL-6 for 2 days. IFNg production was determined by ELISA.
(B) Cells were stimulated as described in (A) but in the presence of IL-12. IFNg production was determined 2 days after activation.
(C) CD41 T cells from SOCS11/1IFNg2/2 (SOCS11/1) or SOCS12/2IFNg2/2 (SOCS12/2) mice were stimulated for 24 hr with anti-CD3 and anti-
CD28 mAbs in the presence of medium or IL-6, rested for 2 hr, and treated with IFNg for 15 min. Phosphorylated STAT1 and STAT1 levels in
whole cell lysates were determined as in Figure 6F.
(D) IL-6 prevents the autoregulation of IFNg expression by increasing SOCS1, thereby inhibiting the IFNgR signaling pathway.
creased Th1 responses after exposure to endotoxin in (Boehm et al., 1997). Some in vivo studies performed in
mice deficient for IFNg or IFNgRa chain indicate that Th1the lung (Xing et al., 1998), and against S. mansoni eggs
(La Flamme et al., 2000). immune responses can be developed in the absence of
IFNg (Muller et al., 1994; Schijns et al., 1994; Swihart etWe show that the inhibition of Th1 differentiation and
the induction of Th2 differentiation by IL-6 are mediated al., 1995). Dighe et al. (1995) have described normal in
vitro CD41 Th1 differentiation in transgenic mice thatby two distinct mechanisms. While Th2 differentiation
by IL-6 is an IL-4-dependent process, the inhibition of express a dominant-negative IFNgRa mutant in T cells.
In contrast, the study by Wakil et al. (1998) demonstratesTh1 differentiation by IL-6 is independent of IL-4. IL-6
directs Th2 development by inducing the initial produc- that IFNg production by CD41 T cells is critical for the
development of in vivo Th1 responses against L. majortion of IL-4 in CD41 T cells (Rinco´n et al., 1997). In this
study, we show that IL-6 inhibits Th1 polarization by or Listeria monocytogenes. Bradley et al. (1996) have
also shown the requirement of IFNg for the differentia-reducing the levels of IFNg gene expression during Th1
differentiation. Signals induced by several receptors tion of both naive and memory CD41 T cells into ef-
fectors producing IFNg using neutralizing anti-IFNgsuch as IL-12R, TcR, and IFNgR participate in the regula-
tion of IFNg gene expression during CD41 T cell activa- mAb. Here, we also demonstrate that IFNgR2/2 CD41 T
cells cannot differentiate into effector Th1 cells, indicat-tion (Trinchieri, 1998; Yang et al., 1999). IL-6 did not
cause a decrease in IFNg production by impairing the ing that IFNg plays a critical role in the differentiation
of CD41 T cells.IL-12 signaling pathway since this inhibitory effect was
observed even in the absence of IL-12 (Figure 2B). In In correlation with the study by Bradley et al. (1996),
we propose that IFNg gene expression is upregulatedaddition, IL-6 does not appear to interfere with the TcR
pathway but interferes with IFNgR-mediated signals, by endogenous IFNg via an autocrine mechanism during
the differentiation of CD41 T cells into effector Th1 cells,since we have shown that IL-6 fails to inhibit IFNg pro-
duction in IFNgRa-deficient CD41 T cells that have nor- similar to IL-4 autoregulation during Th2 differentiation.
The substantial reduction of IFNg levels observed inmal TcR stimulation (Figure 5A). We have therefore dem-
onstrated that IL-6 inhibits Th1 differentiation by IFNgR-deficient CD41 T cells during their differentiation
(Figure 4B) and the enhancement of IFNg gene expres-preventing IFNgR-mediated signaling.
The role of IFNg as an inducer of Th1 differentiation sion by exogenous IFNg (Figure 4D) support this model.
Although the molecular mechanism for the autoregula-during primary Th stimulation remains controversial
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used in the antigen-specific T cell experiment (Figure 1D). The Bor-tion of IFNg gene expression by IFNg remains to be
relia burgdorferi infection studies were done in C3H mice (Jacksondetermined, it is likely to be mediated by STAT1. Several
Laboratory). Wild-type 129/SvJ or IFNgR2/2 129/SvJ mice were pur-STAT binding sites have been identified within an en-
chased from Jackson Laboratory. 15-day-old F1 C57Bl/63129/SvJ
hancer located at the first intron of the IFNg gene and wild-type or SOCS-12/2 mice and adult C57Bl/63129/SvJ IFNg2/2
STAT1 binds to four of them. Additional STAT1 binding or SOCS12/2IFNg2/2 mice were also used.
sites have also been found in the promoter region of the
IFNg gene (Xu et al., 1996). The diminished production of
B. burgdorferi Infections
IFNg by T cells from STAT1-deficient mice (Fallarino A clonal low passaged isolate of B. burgdorferi N40 (cN40) was used
and Gajewski, 1999) provides strong evidence for this throughout the studies. Spirochetes were grown in Barbour-Stoen-
mechanism. The increased level of IFNg in circulation ner-Kelly (BSK) II medium at 348C. Individual mice were inoculated
with 104 spirochetes in the midline of the back by intradermal injec-in mice deficient for the STAT inhibitor SOCS1 (Marine
tion. The animals were euthanized at 14 days and assessed foret al., 1999) and our own data showing that CD41 T
infection by culturing specimens of the blood, urinary bladder, andcells from the SOCS1-deficient mice produce more IFNg
skin (at the inoculation site) in BSK II medium at 338C. Cultures
(Figure 7) also indicate that IFNg signaling upregulates were read after 14 days, a time period sufficient to allow a single
its own gene expression. spirochete to grow to stationary phase (Anguita et al., 1996). B.
We show here that IL-6 inhibits IFNg signaling by burgdorferi infected mice were treated with recombinant human
IL-6 (R&D Systems) every 24 hr for 5 consecutive days, followed byupregulating SOCS1 levels. Recent studies have also
a 2 day resting period, until the mice were euthanized. Mice wereshown that overexpression of SOCS1 in the RAW264
administered 1 mg of IL-6 per injection throughout the period ofmacrophage cell line (Dickensheets et al., 1999) and the
infection in PBS supplemented with 1% normal mouse serum (NMS).
M12 B cell line (Losman et al., 1999) inhibits activation PBS plus 1% NMS was used as a control.
of STAT6 by IL-4. Despite the upregulation of SOCS1
expression by IL-6 (Figure 6), differentiation of Th2 cells
Determination of Cytokine Productionby IL-4 is not inhibited by IL-6 (Rinco´n et al., 1997). In
ELISA assays were performed with purified anti-IFNg, anti-IL-4, andcontrast, IL-6 itself induces Th2 differentiation in an
anti-IL-2 mAbs (2 mg/ml) as capture antibodies, the corresponding
IL-4-dependent manner, suggesting that physiological biotinylated anti-IFNg, anti-IL-4, and anti-IL-2 mAbs (1 mg/ml; Phar-
levels of SOCS1 are not critical for the regulation of the mingen), horseradish peroxidase-conjugated streptavidin (Sigma),
and the TMB microwell peroxidase substrate and stop solution (Kir-IL-4 signaling pathway in CD41 T cells. In correlation,
kegaard & Perry Labs, Inc., Gaithersburg, MD) according to thewhile SOCS1-deficient cells produce augmented levels
recommended protocol (Pharmingen). Recombinant mouse IL-4of IFNg (Figure 7A) the production of IL-4 was not in-
(R&D), IFNg (R&D), and IL-2 (R&D) were used as standards.creased but slightly decreased in these cells (data not
shown). It is possible that other SOCS family members
Cell Preparation and Surface Stainingregulate IL-4 signaling in T cells.
CD41 T cells were isolated from spleen and lymph nodes by negativeAlthough IL-6 can augment a general immune re-
selection as described (Rinco´n and Flavell, 1994) using a combina-sponse by acting as a survival factor for T cells, our
tion of anti-MHC class II (m5/115), anti-CD8 (TIB105), anti-NK1.1,
study demonstrates that IL-6 does not promote all types and anti-Mac1 mAb. Naive CD41 T cells were purified by cell sorting
of CD41-mediated responses since IL-6 is a strong in- using a negatively selected population of CD41 T cells that was
hibitor of CD41 Th1 differentiation. In addition, we pro- stained with FITC anti-CD4 (Pharmingen) and PE-anti-CD44 (Caltag).
The CD41 CD44low population was purified as naive CD41 T cells.vide the molecular mechanism by which IL-6 inhibits
IFNgRa expression on purified CD41 T cells was analyzed using aTh1 differentiation via interference with the signaling
biotinylated anti-IFNgRa mAb (Pharmingen) and Red613-conjugatedpathway induced by IFNg (Figure 7C). We propose that
streptavidin (Gibco-BRL) and flow cytometry.
activation of STAT3 by IL-6 during the activation of naive
CD41 T cells upregulates expression of the SOCS1 gene.
Ribonuclease Protection AssayIncreased levels of SOCS1 inhibit STAT1 phosphoryla-
Total RNA was extracted from cells using Ultraspec RNA Isolationtion induced by endogenous IFNg and prevent the posi-
Reagent (Biotecx Laboratory, Houston TX) as recommended by the
tive autoregulation of IFNg gene expression. Since IL-6 manufacturer. In brief, 4 mg of total RNA was hybridized overnight
promotes CD41 Th2 differentiation (IL-4 dependent) and with [32P]-UTP radiolabeled RNA probes transcribed in vitro from the
inhibits Th1 differentiation (IL-4 independent) by two mCK-1 DNA template provided in RPA kit (Pharmingen). Overlapping
ssRNA on hybridized dsRNAs was digested, and the protectedindependent mechanisms, IL-6 plays an important role
dsRNA duplexes were purified and resolved on urea-denaturingin the balance of Th1/Th2 immune response.
gels. Gels were dried and exposed to Kodak MR film for autoradio-
graphic analysis.
Experimental Procedures
Reagents Electrophoretic Mobility Shift Assay
For T cell activation and differentiation, we have used ConA (Boeh- Nuclear extracts were prepared from stimulated CD41 T cells as
ringer, Manheim), anti-CD3 mAb (145-2C11), anti-CD28 (Phar- previously described (Schreiber et al., 1989; Tugores et al., 1992).
mingen, San Diego, CA), synthetic moth cytochrome c peptide, IL-6 STAT binding reactions were carried out using 2 mg of nuclear pro-
(R&D Inc., Minneapolis, MN), IFNg (R&D), anti-IL-6 mAb (R&D), anti- teins and a [32P]-dCTP-end labeled double stranded oligonucleotide
IFNg mAb (R&D), anti-IL-4 mAb (Pharmingen), and IL-12 kindly pro- containing a high-affinity STAT binding site (m67: 59-GTCGACATTT
vided by Genetics Institute. CCCGTAAATCG-39 (Wagner et al., 1990)). Supershift analysis was
performed by incubating nuclear extracts with 1 ml/reaction of a
control rabbit anti-mouse glutathione S-transferase Ab or rabbitMice
Wild-type B10.BR mice (Jackson Laboratory, Bar Harbor, ME) were anti-mouse STAT3 Ab (Upstate Biotechnologies, Lake Placid, NY)
for 2 hr at 48C before adding the labeled oligo. Samples were electro-used as the source of CD41 T cells for most of the experiments
except where indicated. Cytochrome c transgenic mice (AND) mice phoresed under nondenaturing conditions and exposed to film for
autoradiography.(Kaye et al., 1989) were maintained in the B10.BR background and
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Northern Blotting Endo, T.A., Masura, M., Yokouchi, M., Suzuki, R., Sakamoto, H.,
Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H.,Total RNA from CD41 T cells was isolated as described above. 10 mg
of RNA was separated and transferred to nitrocellulose. Membranes et al. (1997). A new protein containing an SH2 domain that inhibits
JAK kinases. Nature 387, 921–924.were hybridized with a [32P]-labeled SOCS-1 probe generously pro-
vided by Nicos Nicola (Walter and Elisa Hall Institute, Victoria, Aus- Fallarino, F., and Gajewski, T.F. (1999). Cutting edge: differentiation
tralia) Blots were then stripped and reprobed for g-actin. of antitumor CTL in vivo requires host expression of Stat1. J. Immu-
nol. 163, 4109–4113.
Western Blotting Hsieh, C.S., Macatonia, S.E., Tripp, C.S., Wolf, S.F., O’Garra, A., and
STAT1 phosphorylation in response to IFNg treatment was mea- Murphy, K.M. (1993). Development of Th1 CD41 T cells through IL-12
sured by immunoblot analysis using a polyclonal Ab raised against produced by Listeria-induced macrophages. Science 260, 547–549.
STAT1 phosphorylated on Tyrosine 701 (pY701 STAT1: New England
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H.,Biolabs, Beverly, MA) as directed by the manufacturer. Immune
Kamijo, R., Vilcek, J., Zinkernagel, R.M., and Aguet, M. (1993). Im-complexes were detected by enhanced chemiluminescence (Kir-
mune response in mice that lack the interferon-gamma receptor.kegaard & Perry Labs, Inc., Gaithersburg, MD). Blots were then
Science 259, 1742–1745.stripped and re-probed with anti-STAT1 (Transduction Laboratories)
Joseph, S.B., Miner, K.T., and Croft, M. (1998). Augmentation ofas recommended by the manufacturer.
naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.
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